MALAT1 and cancer: As an example of this, the lncRNA MALAT1 has been studied as a potential therapeutic target, and in multiple tumor types; MALAT1 inhibition has demonstrated anti-cancer effects, although these strategies are yet to become routine clinical practice [164].